Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 9
1980 52
1981 46
1982 136
1983 193
1984 219
1985 240
1986 239
1987 279
1988 267
1989 289
1990 300
1991 272
1992 303
1993 230
1994 208
1995 244
1996 234
1997 254
1998 229
1999 263
2000 246
2001 254
2002 212
2003 241
2004 223
2005 228
2006 247
2007 263
2008 262
2009 244
2010 263
2011 261
2012 279
2013 298
2014 301
2015 307
2016 282
2017 248
2018 249
2019 252
2020 257
2021 231
2022 223
2023 193
2024 217
2025 224
2026 70

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,362 results

Results by year

Filters applied: . Clear all
Page 1
Ketoconazole.
Hume AL, Kerkering TM. Hume AL, et al. Drug Intell Clin Pharm. 1983 Mar;17(3):169-74. doi: 10.1177/106002808301700301. Drug Intell Clin Pharm. 1983. PMID: 6301794 Review.
At present, there is very little peer review literature on ketoconazole's effectiveness for several of its approved indications. Gastrointestinal side effects account for the majority of reported adverse reactions; however, preliminary evidence suggests that higher …
At present, there is very little peer review literature on ketoconazole's effectiveness for several of its approved indication …
Onychomycosis.
André J, Achten G. André J, et al. Int J Dermatol. 1987 Oct;26(8):481-90. doi: 10.1111/j.1365-4362.1987.tb02287.x. Int J Dermatol. 1987. PMID: 2960631 Review. No abstract available.
Evaluation of ketoconazole.
Sohn CA. Sohn CA. Clin Pharm. 1982 May-Jun;1(3):217-24. Clin Pharm. 1982. PMID: 6309466 Review.
Controlled, comparative, double-blind trials of ketoconazole versus older agents are generally unavailable. Nausea and vomiting are the most common adverse effects encountered with ketoconazole. ...Ketoconazole is a promising new drug, especially when one con …
Controlled, comparative, double-blind trials of ketoconazole versus older agents are generally unavailable. Nausea and vomiting are t …
Ketoconazole.
Deutsch PH, Quintiliani R. Deutsch PH, et al. Conn Med. 1984 Apr;48(4):216-21. Conn Med. 1984. PMID: 6325087 Review. No abstract available.
Ketoconazole.
Turner T. Turner T. Med J Aust. 1983 Nov 12;2(10):514. doi: 10.5694/j.1326-5377.1983.tb122623.x. Med J Aust. 1983. PMID: 6314105 No abstract available.
Blastomycosis.
Murphy PA. Murphy PA. JAMA. 1989 Jun 2;261(21):3159-62. JAMA. 1989. PMID: 2716144 No abstract available.
Ketoconazole in the treatment of coccidioidomycosis.
Galgiani JN. Galgiani JN. Drugs. 1983 Oct;26(4):355-63. doi: 10.2165/00003495-198326040-00005. Drugs. 1983. PMID: 6313321 Review.
The inhibition of Coccidioides immitis observed by in vitro susceptibility testing has been corroborated in murine studies in which ketoconazole therapy has led to survival in otherwise lethally infected animals. In man, absorption of ketoconazole from the gastroint …
The inhibition of Coccidioides immitis observed by in vitro susceptibility testing has been corroborated in murine studies in which ketoc …
Itraconazole.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1993 Jan 22;35(888):7-9. Med Lett Drugs Ther. 1993. PMID: 8380485 No abstract available.
[Ketoconazole].
Bohand X, Simon F. Bohand X, et al. Med Trop (Mars). 1999;59(3):227-8. Med Trop (Mars). 1999. PMID: 10701196 French. No abstract available.
The Rise and Fall of Oral Ketoconazole.
Gupta AK, Lyons DC. Gupta AK, et al. J Cutan Med Surg. 2015 Jul-Aug;19(4):352-7. doi: 10.1177/1203475415574970. Epub 2015 Mar 5. J Cutan Med Surg. 2015. PMID: 25775613 Review.
BACKGROUND: Ketoconazole was the first broad-spectrum oral antifungal agent available to treat systemic and superficial mycoses. ...Today, oral ketoconazole is only indicated for endemic mycoses, where alternatives are not available or feasible. ...
BACKGROUND: Ketoconazole was the first broad-spectrum oral antifungal agent available to treat systemic and superficial mycoses. ...T …
10,362 results
You have reached the last available page of results. Please see the User Guide for more information.